Skip to main content
. 2022 Jun 6;2022(6):CD011574. doi: 10.1002/14651858.CD011574.pub2

22.4. Analysis.

22.4

Comparison 22: Sensitivity analysis 2: excluding studies with unclear or high risk of bias on random sequence generation, Outcome 4: Number of fallers ‐ cholinesterase inhibitor vs placebo